Colorado bill for protection of people with eating disorders amended to remove restrictions to dietary supplements
A Colorado Senate Bill (SB 23-176) titled “Protections For People With An Eating Disorder” has been amended to remove restrictions to the sale of dietary supplements marketed for weight management.
Photo © Shutterstock.com/bixstock
A Colorado Senate Bill (SB 23-176) titled “Protections For People With An Eating Disorder” has been amended to remove restrictions to the sale of dietary supplements marketed for weight management. Industry trade groups and stakeholders such as the Natural Products Association (NPA; Washington, D.C.) and Natural Grocers have been actively lobbying lawmakers in Colorado to protect consumer access to dietary supplements. Similar bills targeting dietary supplements have been recently vetoed by governors in the states of New York and California.
“This is a big victory for consumer access in Colorado and we want to thank Majority Leader Moreno for his leadership and willingness to collaborate on a good solution. We wish more state lawmakers in other capitals would exercise the same approach to science, reason, and common sense,” said Kyle Turk, director of government affairs for the Natural Products Association (NPA; Washington, D.C.). “Far too often, legislators simply ignore science, data and the consequences of poorly-designed legislation that ends up hurting consumers, but this was not one of those instances. Our team immediately had the opportunity to share the impact language in the bill would have on consumers and industry stakeholders. We are grateful to the Majority leader and other stakeholders in the eating disorder community who considered the facts and recognized that there is no data point connecting eating disorders and the use of dietary supplements.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
